Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

Titan Transform is a cutting-edge growth hormone activator spray formulated to support men who want to boost size, length, ...

As we get older, HGH levels drop-by up to 50% every 7 years past age 30-leading to fat gain, decreased energy, slow ...